J&J expedites Phase I/IIa trial of Covid-19 vaccine candidate
J&J will perform the Phase I/IIa trial in US and Belgium. Credit:
Open Grid Scheduler / Grid Engine.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more